(From the US FDA press release) Today, the U.S. Food and Drug Administration approved Narcan, 4 milligram (mg) naloxone hydrochloride nasal spray for over-the-counter (OTC), nonprescription, use – the first naloxone product approved for use without a prescription. Naloxone is a medication that rapidly reverses the effects of opioid overdose and is the standard treatment for opioid overdose. Today’s action paves the way for the life-saving medication to reverse an opioid overdose to be sold directly to consumers in places like drug stores, convenience stores, grocery stores and gas stations, as well as online.  Read the complete press release. Posted March 29, 2023

January 25, 2023 NIDA International Program is accepting applications for international postdoctoral researchers for the INVEST Drug Use and Addiction Research Fellowship. This combines postdoctoral research training in the United States with professional development activities and grant-writing guidance to form a unique program for drug use and addiction scientists. Fellowship: The 12-month INVEST fellowship provides rigorous postdoctoral research training with a NIDA grantee at a U.S. institution, professional development activities that help establish personal relationships with NIDA grantees and NIDA officials, a stipend for living and personal expenses, and an allowance to cover the cost of health insurance and professional development activities. Eligibility: INVEST applicants are required to be international researchers with a doctoral degree and a minimum of 2 years of postdoctoral experience, to have citizenship or permanent residency in a country other than the United States, and to have a proficiency in written and spoken English. INVEST Mentors: INVEST mentors must be NIDA-funded researchers in the United States. Their NIDA-funded grants must be active throughout the proposed fellowship period. Reference: Steven W. Gust, Judy McCormally, & Nei-Hyun Park (2021). Increasing evidence-based substance use interventions globally: The National Institute on Drug Abuse postdoctoral fellowships, Substance Abuse, 42(4):397-406, https://doi.org/10.1080/08897077.2021.1975874. Contact NIDA: For questions about the INVEST Postdoctoral Fellowship, contact ip@nida.nih.gov.